Notice 8 May 2025 patent infringement, u.s., trade commission, regulatory compliance, pharmaceutical industry

💊ITC Investigation on Drug Products and Patent Violations

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 2, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of BioMarin Pharmaceutical Inc. of Novato, California. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain drug products containing C-type natriuretic peptide variants and components thereof by reason of the infringement of certain claims of U.S. Reissue Patent No. RE48,267 (the "RE'267 patent"). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

Learn More
Rule 8 May 2025 airworthiness directives, aviation safety, regulatory compliance, safety, aircraft safety, incorporation by reference, aircraft, boeing, aviation, air transportation

✈️New Airworthiness Directive for Boeing Airplanes Addresses Elevator Safety

The FAA is adopting a new airworthiness directive (AD) for all The Boeing Company Model DC-9-81 (MD-81), DC-9-82 (MD-82), DC-9-83 (MD- 83), DC 9-87 (MD-87), and MD-88 airplanes, and Model DC-9-10, DC-9-20, DC-9-30, DC-9-40, and DC-9-50 series airplanes. This AD was prompted by the discovery of jammed elevators during takeoff. This AD requires revising the "Certificate Limitations" section of the existing airplane flight manual (AFM) to include a procedure to confirm elevator surfaces are not jammed in the trailing edge down (TED) position. The FAA is issuing this AD to address the unsafe condition on these products.

Learn More
Notice 8 May 2025 regulatory compliance, university, museum, florida, native american

🏺Notice on Repatriation of Cultural Artifacts by University of Florida

In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the University of Florida, Florida Museum of Natural History (FLMNH) has completed an inventory of human remains and associated funerary objects and has determined that there is a cultural affiliation between the human remains and associated funerary objects and Indian Tribes or Native Hawaiian organizations in this notice.

Learn More
Notice 8 May 2025 advisory committee, agriculture, usda, regulatory compliance, grain inspection

🌾Notice of Grain Inspection Advisory Committee Meeting - 2025

Pursuant to the Federal Advisory Committee Act, this notice announces an upcoming meeting of the Grain Inspection Advisory Committee (Committee). The Committee meets no less than once annually to advise the Secretary of Agriculture on the programs and services delivered by the Agricultural Marketing Service (AMS) under the U.S. Grain Standards Act. Recommendations by the Committee help AMS meet the needs of its customers, who operate in a dynamic and changing marketplace.

Learn More
Notice 8 May 2025 negotiated service agreement, regulatory compliance, business logistics, shipping, postal service

📦Priority Mail Negotiated Service Agreement and Its Business Impact

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

Learn More
Notice 8 May 2025 fda, pharmaceuticals, regulatory compliance, public comment, oncology, drug approval

💊FDA Oncologic Drugs Advisory Committee Meeting Notice

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

Learn More
Notice 8 May 2025 logistics, regulatory compliance, business agreements, shipping, postal service

📦USPS Priority Mail Contract Notice and Regulatory Update

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

Learn More
Notice 8 May 2025 postal service, regulatory compliance, negotiated service agreement, shipping

📦USPS Notice on Priority Mail and Ground Advantage Agreement

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

Learn More
Notice 8 May 2025 priority mail, regulatory compliance, business agreements, shipping, ground advantage, postal service

📦Postal Service Notice on Priority Mail and USPS Ground Advantage Changes

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

Learn More
Notice 8 May 2025 commodity futures trading commission, regulatory compliance, swaps, information collection, financial services

📄CFTC Notice on Information Collection Activities for Swaps

In compliance with the Paperwork Reduction Act of 1995 ("PRA"), this notice announces that the Information Collection Request ("ICR") abstracted below has been forwarded to the Office of Information and Regulatory Affairs ("OIRA"), of the Office of Management and Budget ("OMB"), for review and comment. The ICR describes the nature of the information collection and its expected costs and burden.

Learn More